ZNF396 Activators
ZNF396 Activators encompass a range of chemical compounds that indirectly enhance the functional activity of ZNF396 through modifications in chromatin structure and DNA methylation patterns. Histone deacetylase inhibitors like Trichostatin A, Vorinostat, Sodium Butyrate, M344, Entinostat, Romidepsin, Panobinostat, and Belinostat play a pivotal role in facilitating ZNF396's transcriptional regulatory functions. These compounds act by relaxing the chromatin structure, thereby making the DNA more accessible for ZNF396 binding. This alteration in chromatin architecture is crucial for ZNF396, as it enables the protein to bind more effectively to DNA, enhancing its ability to regulate gene expression. The functional outcome is a more potent transcriptional regulation by ZNF396, stemming from its increased interaction with DNA.
In parallel, DNA methyltransferase inhibitors like 5-Azacytidine, RG108, SGI-1027, and Decitabine contribute to the enhanced activity of ZNF396 by a different mechanism. These compounds reduce DNA methylation, a modification that typically suppresses gene expression by restricting transcription factor access. By inhibiting DNA methylation, these chemicals increase the potential binding sites available for ZNF396 on the DNA, thus amplifying its capacity to regulate transcription. This demethylation effect is particularly significant for ZNF396, as its binding and regulatory activities are highly dependent on the methylation status of DNA. Together, these activators, through their targeted actions on chromatin remodeling and DNA methylation, effectively bolster the transcriptional regulatory role of ZNF396, enhancing its function in the cellular context without directly interacting with the protein or affecting its expression levels.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, enhances ZNF396 activity by altering chromatin structure. This leads to more accessible DNA for ZNF396 binding, thereby facilitating its role in transcription regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, indirectly enhances ZNF396 by reducing DNA methylation. This can increase ZNF396's binding to previously methylated DNA regions, enhancing its transcriptional regulatory functions. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, operates similarly to Trichostatin A. It enhances ZNF396 function by making chromatin more accessible for DNA binding and transcriptional regulation by ZNF396. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a short-chain fatty acid and histone deacetylase inhibitor, indirectly increases ZNF396 activity by relaxing chromatin structure, thus facilitating ZNF396's access to DNA. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108, a DNA methyltransferase inhibitor, indirectly promotes ZNF396 activity by decreasing DNA methylation. This potentially increases ZNF396's binding sites and enhances its transcriptional regulatory activities. | ||||||
M 344 | 251456-60-7 | sc-203124 sc-203124A | 1 mg 5 mg | $109.00 $322.00 | 8 | |
M344, a potent histone deacetylase inhibitor, enhances ZNF396's transcriptional regulation by increasing chromatin accessibility, allowing more effective DNA binding by ZNF396. | ||||||
SGI-1027 | 1020149-73-8 | sc-473875 | 10 mg | $213.00 | ||
SGI-1027, a DNA methyltransferase inhibitor, enhances ZNF396 function by demethylating DNA. This can lead to increased binding of ZNF396 to DNA, facilitating its role in transcription regulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat, a selective histone deacetylase inhibitor, indirectly enhances ZNF396 activity by promoting chromatin relaxation, which aids in ZNF396's DNA binding and transcriptional regulatory roles. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, increases ZNF396 function by reducing DNA methylation, potentially enhancing ZNF396's ability to bind DNA and regulate transcription. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin, a histone deacetylase inhibitor, enhances ZNF396's transcriptional regulation by altering chromatin structure, thereby improving ZNF396's access to its DNA binding sites. | ||||||